CHE

SEC source: 0001193125-26-410313 · ownership.xml · derivative · entry 3

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,097

Underlying: Capital Stock · 12,099 shares

Expires 2026-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022.

SEC source: 0001193125-26-410313 · ownership.xml · nonDerivative · entry 2

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,851

F1 · kind: Payment of purchase price and tax obligation on stock option exercise.

SEC source: 0001193125-26-410313 · ownership.xml · nonDerivative · entry 1

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,011

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-408869 · ownership.xml · nonDerivative · entry 1

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,418

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

SEC source: 0001193125-26-406299 · ownership.xml · derivative · entry 3

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,089

Underlying: Capital Stock · 4,629 shares

Expires 2026-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022.

SEC source: 0001193125-26-406299 · ownership.xml · nonDerivative · entry 2

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,840

F1 · kind: Payment of purchase price and tax obligation on stock option exercise.

SEC source: 0001193125-26-406299 · ownership.xml · nonDerivative · entry 1

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-396365 · ownership.xml · nonDerivative · entry 1

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,418

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.00 to $502.05. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

SEC source: 0001193125-26-362146 · ownership.xml · nonDerivative · entry 1

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,912

SEC source: 0001193125-26-362133 · ownership.xml · nonDerivative · entry 1

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,418

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.62 to $542.53. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

SEC source: 0001193125-26-342087 · ownership.xml · derivative · entry 3

Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,281

Underlying: Capital Stock · 6,786 shares

Expires 2026-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022.

SEC source: 0001193125-26-342087 · ownership.xml · nonDerivative · entry 2

Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,344

F1 · kind: Payment of purchase price and tax obligation on stock option exercise.

SEC source: 0001193125-26-342087 · ownership.xml · nonDerivative · entry 1

Judkins Brian C · CIK 0001823398 · VP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,222

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-337649 · ownership.xml · derivative · entry 3

Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,220

Underlying: Capital Stock · 2,599 shares

Expires 2026-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022.

SEC source: 0001193125-26-337649 · ownership.xml · nonDerivative · entry 2

Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,181

F1 · kind: Payment of purchase price and tax obligation on stock option exercise.

SEC source: 0001193125-26-337649 · ownership.xml · nonDerivative · entry 1

Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-331690 · ownership.xml · derivative · entry 4

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 264,158

Underlying: Capital Stock · 2,001 shares

Expires 2026-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022.

SEC source: 0001193125-26-331690 · ownership.xml · nonDerivative · entry 3

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,418

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.59 to $543.50. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) of this Form 4.

SEC source: 0001193125-26-330302 · ownership.xml · nonDerivative · entry 1

GRACE PATRICK P · CIK 0001230970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,533

SEC source: 0001193125-26-331690 · ownership.xml · nonDerivative · entry 2

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,418

F1 · kind: Payment of purchase price and tax obligation on stock option exercise.

SEC source: 0001193125-26-331690 · ownership.xml · nonDerivative · entry 1

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,220

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-26-265474 · ownership.xml · nonDerivative · entry 1

LINDELL ANDREA R · CIK 0001224643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,578

SEC source: 0001193125-26-248086 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,209

SEC source: 0001193125-26-229860 · ownership.xml · nonDerivative · entry 1

WALSH GEORGE J III · CIK 0001207140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,709

F1 · acquired: Award of stock

SEC source: 0001193125-26-229842 · ownership.xml · nonDerivative · entry 1

Mount John Meredith Jr. · CIK 0001942414 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,316

F1 · acquired: Award of stock

SEC source: 0001193125-26-229837 · ownership.xml · nonDerivative · entry 1

McCarthy Eileen P · CIK 0001978134 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,241

F1 · acquired: Award of stock

SEC source: 0001193125-26-229828 · ownership.xml · nonDerivative · entry 1

LINDELL ANDREA R · CIK 0001224643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,925

F1 · acquired: Award of stock

SEC source: 0001193125-26-229822 · ownership.xml · nonDerivative · entry 1

Heaney Christopher J · CIK 0001811615 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,775

F1 · acquired: Award of stock

SEC source: 0001193125-26-229815 · ownership.xml · nonDerivative · entry 1

GRACE PATRICK P · CIK 0001230970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,723

F1 · acquired: Award of stock

SEC source: 0001193125-26-229800 · ownership.xml · nonDerivative · entry 1

DeLyons Ron · CIK 0001811257 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,052

F1 · acquired: Award of stock

SEC source: 0001193125-26-214481 · ownership.xml · nonDerivative · entry 1

GRACE PATRICK P · CIK 0001230970 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,337

SEC source: 0001193125-26-203623 · ownership.xml · nonDerivative · entry 1

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,219

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $418.99 to $424.95. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

SEC source: 0001193125-26-131183 · ownership.xml · nonDerivative · entry 1

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,219

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.76 to $373.24. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

SEC source: 0001193125-26-105545 · ownership.xml · nonDerivative · entry 1

MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,719

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.31 to $404.68. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

SEC source: 0001193125-26-054949 · ownership.xml · derivative · entry 6

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,524

Underlying: Capital Stock · 960 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock

F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.

F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.

SEC source: 0001193125-26-054949 · ownership.xml · derivative · entry 5

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,564

Underlying: Capital Stock · 402 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

SEC source: 0001193125-26-054949 · ownership.xml · derivative · entry 4

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,966

Underlying: Capital Stock · 402 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

SEC source: 0001193125-26-054949 · ownership.xml · nonDerivative · entry 3

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,912

F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs.

SEC source: 0001193125-26-054949 · ownership.xml · nonDerivative · entry 2

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target.

SEC source: 0001193125-26-054949 · ownership.xml · nonDerivative · entry 1

LEE SPENCER S · CIK 0001207134 · executive vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target.

SEC source: 0001193125-26-054877 · ownership.xml · derivative · entry 6

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 988

Underlying: Capital Stock · 374 shares

Expires not disclosed

F7 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock

F8 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.

F8 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.

SEC source: 0001193125-26-054877 · ownership.xml · derivative · entry 5

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 614

Underlying: Capital Stock · 160 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F6 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

F6 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

SEC source: 0001193125-26-054877 · ownership.xml · derivative · entry 4

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 774

Underlying: Capital Stock · 160 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F6 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

F6 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

SEC source: 0001193125-26-054877 · ownership.xml · nonDerivative · entry 3

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,481

F4 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs.

SEC source: 0001193125-26-054877 · ownership.xml · nonDerivative · entry 2

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2023 through December 31, 2025, compared to a defined peer group of companies. The Company's performance ranked in the 7th percentile of that group, yielding an award of 0%; including the reinvestment of dividends paid during such period, the award is 0% of target.

SEC source: 0001193125-26-054877 · ownership.xml · nonDerivative · entry 1

HUTTON THOMAS C · CIK 0001207131 · Director · vice president

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The number of performance stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2023 through December 31, 2025. The actual performance of $67.67 exceeded the maximum payout threshold of $66.46 and therefore yielded an award of 123% of target; including the reinvestment of dividends paid during such period, the award is 124.1% of target.

F2 · balance_after: Administrative error from 8/7/24 filing; previous holdings were ouverstated by 673 shares

SEC source: 0001193125-26-054514 · ownership.xml · derivative · entry 6

Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,212

Underlying: Capital Stock · 1,142 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock

F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.

F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.

SEC source: 0001193125-26-054514 · ownership.xml · derivative · entry 5

Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,070

Underlying: Capital Stock · 220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

SEC source: 0001193125-26-054514 · ownership.xml · derivative · entry 4

Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,290

Underlying: Capital Stock · 220 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

F5 · derivative.expiration_date: PSUs awarded February 17, 2023 vest based on achievement of performance targets over a period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026.

SEC source: 0001193125-26-054514 · ownership.xml · nonDerivative · entry 3

Wherley Joel L · CIK 0002083070 · CEO - Vitas Healthcare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 852

F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs.